关注
Michael Farwell
Michael Farwell
在 pennmedicine.upenn.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
AC Huang, RJ Orlowski, X Xu, R Mick, SM George, PK Yan, S Manne, ...
Nature medicine 25 (3), 454-461, 2019
5732019
PET/CT imaging in cancer: current applications and future directions
MD Farwell, DA Pryma, DA Mankoff
Cancer 120 (22), 3433-3445, 2014
2592014
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
V Narayan, JS Barber-Rotenberg, IY Jung, SF Lacey, AJ Rech, MM Davis, ...
Nature medicine 28 (4), 724-734, 2022
2312022
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
RN Amaria, AM Menzies, EM Burton, RA Scolyer, MT Tetzlaff, ...
The Lancet Oncology 20 (7), e378-e389, 2019
2012019
First-in-humans imaging with 89Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting
N Pandit-Taskar, MA Postow, MD Hellmann, JJ Harding, CA Barker, ...
Journal of Nuclear Medicine 61 (4), 512-519, 2020
1952020
Positron emission tomography
K Lameka, MD Farwell, M Ichise
Handbook of clinical neurology 135, 209-227, 2016
1262016
A PET imaging agent for evaluating PARP-1 expression in ovarian cancer
M Makvandi, A Pantel, L Schwartz, E Schubert, K Xu, CJ Hsieh, C Hou, ...
The Journal of clinical investigation 128 (5), 2116-2126, 2018
1232018
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours
A Maity, R Mick, AC Huang, SM George, MD Farwell, JN Lukens, ...
British journal of cancer 119 (10), 1200-1207, 2018
982018
Imaging CAR T cell trafficking with eDHFR as a PET reporter gene
MA Sellmyer, SA Richman, K Lohith, C Hou, CC Weng, RH Mach, ...
Molecular Therapy 28 (1), 42-51, 2020
832020
CD8-targeted PET imaging of tumor-infiltrating T cells in patients with cancer: a phase I first-in-humans study of 89Zr-Df-IAB22M2C, a radiolabeled anti-CD8 minibody
MD Farwell, RF Gamache, H Babazada, MD Hellmann, JJ Harding, ...
Journal of Nuclear Medicine 63 (5), 720-726, 2022
792022
Making molecular imaging a clinical tool for precision oncology: a review
DA Mankoff, MD Farwell, AS Clark, DA Pryma
JAMA oncology 3 (5), 695-701, 2017
762017
Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor–T-cell therapy in B-cell non-Hodgkin lymphomas
NN Shah, SJ Nagle, DA Torigian, MD Farwell, WT Hwang, N Frey, ...
Cytotherapy 20 (12), 1415-1418, 2018
542018
Diagnostic accuracy of amino acid and FDG-PET in differentiating brain metastasis recurrence from radionecrosis after radiotherapy: a systematic review and meta-analysis
H Li, L Deng, HX Bai, J Sun, Y Cao, Y Tao, MD Farwell, P Zhang, B Xiao, ...
American Journal of Neuroradiology 39 (2), 280-288, 2018
512018
Development of companion diagnostics
DA Mankoff, CE Edmonds, MD Farwell, DA Pryma
Seminars in nuclear medicine 46 (1), 47-56, 2016
462016
A phase I clinical trial of PSMA-directed/TGFβ-insensitive CAR-T cells in metastatic castration-resistant prostate cancer.
V Narayan, W Gladney, G Plesa, N Vapiwala, E Carpenter, SL Maude, ...
Journal of Clinical Oncology 37 (7_suppl), TPS347-TPS347, 2019
432019
Synthesis and reactions of Cp-linked phosphine complexes of rhodium
L Lefort, TW Crane, MD Farwell, DM Baruch, JA Kaeuper, RJ Lachicotte, ...
Organometallics 17 (18), 3889-3899, 1998
431998
Artificial intelligence and radiomics: Fundamentals, applications, and challenges in immunotherapy
L Dercle, J McGale, S Sun, A Marabelle, R Yeh, E Deutsch, FZ Mokrane, ...
Journal for Immunotherapy of Cancer 10 (9), 2022
362022
Diagnostic accuracy of SPECT, PET, and MRS for primary central nervous system lymphoma in HIV patients: a systematic review and meta-analysis
M Yang, J Sun, HX Bai, Y Tao, X Tang, Z Zhang, J Zhou, MD Farwell, ...
Medicine 96 (19), e6676, 2017
342017
Positron emission tomography imaging of poly–(adenosine diphosphate–ribose) polymerase 1 expression in breast cancer: a nonrandomized clinical trial
ES McDonald, RK Doot, AR Pantel, MD Farwell, RH Mach, KN Maxwell, ...
JAMA oncology 6 (6), 921-923, 2020
302020
Breast cancer 18F-ISO-1 uptake as a marker of proliferation status
ES McDonald, RK Doot, AJ Young, EK Schubert, J Tchou, DA Pryma, ...
Journal of Nuclear Medicine 61 (5), 665-670, 2020
262020
系统目前无法执行此操作,请稍后再试。
文章 1–20